Lanthanide-based nanoparticles as photothermal agents, radiosensitizers, and swir emitters for cancer therapy

F. Bray, J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre, A. Jemal. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68(6): 394-424.

H. Sung, J. Ferlay, R. L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021; 71(3): 209-249.

M. M. Alvi, R. E. Nicoletto, B. A. Eshmawi, H. K. Kim, C. R. Cammarata, C. M. 3rd Ofner. Intracellular trafficking and cytotoxicity of a gelatine-doxorubicin conjugate in two breast cancer cell lines. J Drug Target 2020; 28(5): 487-499.

R. B. Diasio, B. E. Harris. Clinical pharmacology of 5-fluorouracil. Clin Pharmacokinet 1989; 16(4): 215-237.

D. B. Longley, D. P. Harkin, P. G. Johnston. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 2003; 3(5): 330-338.

R. Baskar, K. A. Lee, R. Yeo, K. W. Yeoh. Cancer and radiation therapy: current advances and future directions. Int J Med Sci 2012; 9(3): 193-199.

G. Delaney, S. Jacob, C. Featherstone, M. Barton. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 2005; 104(6): 1129-1137.

I. I. Verginadis, D. E. Citrin, B. Ky, S. J. Feigenberg, A. G. Georgakilas, C. E. Hill-Kayser. Radiotherapy toxicities: mechanisms, management, and future directions. Lancet 2025; 405(10475): 338-352.

D. Chen, R. Parsa, K. Chauhan, J. Lukovic, K. Han, A. Taggar. Review of brachytherapy clinical trials: a cross-sectional analysis of ClinicalTrials.gov. Radiat Oncol 2024; 19(1): 22.

R. Abdul Jalil, Y. Zhang. Biocompatibility of silica coated NaYF(4) upconversion fluorescent nanocrystals. Biomaterials 2008; 29(30): 4122-4128.

J. P. O’Connor, E. O. Aboagye, J. E. Adams, H. J. Aerts, S. F. Barrington, A. J. Beer. Imaging biomarker roadmap for cancer studies. Nat Rev Clin Oncol 2017; 14(3): 169-186.

G. Hong, A. L. Antaris, H. Dai. Near-infrared fluorophores for biomedical imaging. Nat Biomed Eng 2017; 1(1): 0010.

J. Y. Park, Y. Chang, G. H. Lee. Multi-modal imaging and cancer therapy using lanthanide oxide nanoparticles: current status and perspectives. Curr Med Chem 2015; 22(5): 569-581.

G. Chen, I. Roy, C. Yang, P. N. Prasad. Nanochemistry and Nanomedicine for Nanoparticle-based Diagnostics and Therapy. Chem Rev 2016; 116(5): 2826-2885.

Y. Xia, R. Yang, J. Zhu, H. Wang, Y. Li, J. Fan. Engineered nanomaterials trigger abscopal effect in immunotherapy of metastatic cancers. Front Bioeng Biotechnol 2022; 10: 890257.

Y. Zhong, Z. Ma, F. Wang, X. Wang, Y. Yang, Y. Liu. In vivo molecular imaging for immunotherapy using ultra-bright near-infrared-IIb rare-earth nanoparticles. Nat Biotechnol 2019; 37(11): 1322-1331.

X. Wu, G. Chen, J. Shen, Z. Li, Y. Zhang, G. Han. Upconversion nanoparticles: a versatile solution to multiscale biological imaging. Bioconjug Chem 2015; 26(2): 166-175.

F. Chen, S. Goel, H. F. Valdovinos, H. Luo, R. Hernandez, T. E. Barnhart. In Vivo Integrity and Biological Fate of Chelator-Free Zirconium-89-Labeled Mesoporous Silica Nanoparticles. ACS Nano 2015; 9(8): 7950-7959.

Y. Q. Liu, L. Y. Qin, H. J. Li, Y. X. Wang, R. Zhang, J. M. Shi. Application of lanthanide-doped upconversion nanoparticles for cancer treatment: a review. Nanomedicine (Lond) 2021; 16(24): 2207-2242.

L. Huang, E. Kakadiaris, T. Vaneckova, K. Huang, M. Vaculovicova, G. Han. Designing next generation of photon upconversion: recent advances in organic triplet-triplet annihilation upconversion nanoparticles. Biomaterials 2019; 201: 77-86.

M. Yang, Y. Huang, Z. Chen, Q. Ye, Z. Zeng, X. You. Synthetic carbon-based lanthanide upconversion nanoparticles for enhanced photothermal therapy. Nat Commun 2025; 16(1): 6343.

I. A. Khan, T. Yu, M. Yang, J. Liu, Z. Chen. A Systematic Review of Toxicity, Biodistribution, and Biosafety in Upconversion Nanomaterials: Critical Insights into Toxicity Mitigation Strategies and Future Directions for Safe Applications. BME Front 2025; 6: 0120.

S. Chen, T. Han, B. Z. Tang. Functional Polymeric Micromaterials Based on Aggregation-Induced Emission Luminogens. Adv Funct Mater 2023; 33(51): 2307267.

M. J. Page, J. E. McKenzie, P. M. Bossuyt, I. Boutron, T. C. Hoffmann, C. D. Mulrow. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71.

N. R. Haddaway, M. J. Page, C. C. Pritchard, L. A. McGuinness. PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis. Campbell Syst Rev 2022; 18(2): e1230.

X. Jiang, Y. Wang, D. Xu, B. Lin, F. Yang, R. Lv. Lanthanide-Based Nanocomposites for Photothermal Therapy under Near-Infrared Laser: Relationship between Light and Heat, Biostability, and Reaction Temperature. Langmuir 2020; 36(15): 4033-4043.

L. Zhao, X. Zhang, X. Wang, X. Guan, W. Zhang, J. Ma. Recent advances in selective photothermal therapy of tumor. J Nanobiotechnology 2021; 19(1): 335.

M. Salimi, S. Mosca, B. Gardner, F. Palombo, P. Matousek, N. Stone. Nanoparticle-Mediated Photothermal Therapy Limitation in Clinical Applications Regarding Pain Management. Nanomaterials (Basel) 2022; 12(6):

Y. Zhang, X. Zhu, J. Zhang, Y. Wu, J. Liu, Y. Zhang. Synergistic upconversion photodynamic and photothermal therapy under cold near-infrared excitation. J Colloid Interface Sci 2021; 600: 513-529.

X. Cui, Q. Ruan, X. Zhuo, X. Xia, J. Hu, R. Fu. Photothermal Nanomaterials: A Powerf

Comments (0)

No login
gif